Munchen
Germany
12
2012-01-19
The entities that hold a legal rights for patent applications filed by inventor Leyrer Sonja:
Sonja Leyrer from Munchen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
#2 | 2012-01-19Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs)
#3 | 2012-01-12Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)
#4 | 2011-12-15Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)
#5 | 2010-08-05Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
#6 | 2010-07-22Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
#7 | 2010-06-03Flavivirus NS1 subunit vaccine
#8 | 2010-02-25FLAVIVIRUS NS1 SUBUNIT VACCINE
#9 | 2008-05-15Promoters for expression in modified vaccinia virus Ankara
#10 | 2006-08-24Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara
#11 | 2006-07-20MVA virus vector expressing dengue NS1 protein
#12 | 2006-07-13Recombinant poxvirus comprising at least two compox ATI promoters
3071045 ⎘